two crossover phases were use in a randomized , double-blind , placebo-controlled manner : continuous nitroglycerin therapy ( patches containing active drug worn for 24 hours ) and intermittent nitroglycerin therapy ( 12-hour active drug followed by a 12-hour nitrate-free period ) .
C0017887
nitroglycerin
C0028125
nitrate